The Oncology Institute, Inc. TOI Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from The Oncology Institute, Inc.’s reported figures.
Based on trailing twelve months.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s free cash flow margin?
- The Oncology Institute, Inc. (TOI) reported free cash flow margin of -5.1% in Q1 2026.
- What is the long-term trend for The Oncology Institute, Inc.'s free cash flow margin?
- Over 4 years (2020 to 2025), The Oncology Institute, Inc.'s free cash flow margin has grown at a 100.9% compound annual growth rate (CAGR), from -0.4% to -6%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.